Search results
This document presents official recommendations of the American Association for the Study of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC) occur-ring in the setting of adults with cirrhosis.
29 sty 2024 · Treatment protocols for hepatocellular carcinoma (HCC) are provided below. Historically, HCC treatment protocols have been divided into two broad categories: for resectable and for...
This guidance provides a data-supported approach to the diagnosis, staging, and treatment of patients diag-nosed with hepatocellular carcinoma (HCC). A guid-ance document is different from a guideline.
hepatocellular carcinoma. Key content includes diagnostic criteria, staging of disease, treatment plans and follow-up. The ESMO CPGs are intended to provide you with a set of recommendations for the best standards of care, using evidence-based medicine.
Management of Hepatocellular Carcinoma: An Update Jordi Bruix1 and Morris Sherman2 Preamble The recommendations provided in this document pro-vide a data-supported approach to the diagnosis, staging and treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on the following: (a)
4 sty 2024 · This review explores the dynamic landscape of hepatocellular carcinoma (HCC) treatment, emphasizing on recent developments across various stages and therapeutic approaches. Although curative strategies such as hepatectomy and thermal ablation are standard for early-stage cases, high relapse rates drive investigations into adjuvant and ...
31 sty 2019 · Hepatocellular carcinoma: ESMO Clinical Practice † Guidelines for diagnosis, treatment and follow-up. *Correspondence to: ESMO Guidelines Committee, ESMO Head Office, Via Ginevra 4, 6900 Lugano, Switzerland. E-mail: clinicalguidelines@esmo.org. †Approved by the ESMO Guidelines Committee: August 2018.
